Fund Holdings — Aisling Capital Management LP

Total Portfolio Value:
$288.45M
Total Bought:
$218.3K
Total Sold:
$22.79M
Net Transaction:
-$22.57M
Notable People:
Andrew Newman Schiff, Steven Arnote Elms, Aisling Capital Partners Iv Llc
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
BridgeBio Pharma, Inc.(BBIO)6,068,1256,068,1250$166.51M$209.78M72.72%+$43.27M
Verona Pharma plc (VRNA)ADS1,115,352615,352-500,000$51.80M$39.07M13.54%-$12.73M
Syndax Pharmaceuticals, Inc.(SNDX)1,025,0001,025,0000$13.55M$12.59M4.36%-$963.5K
Bicara Therapeutics Inc. (BCAX)568,919568,9190$9.91M$7.41M2.57%-$2.50M
Monte Rosa Therapeutics, Inc.(GLUE)1,472,3311,472,3310$10.22M$6.83M2.37%-$3.39M
Nuvation Bio Inc.CL A(NUVB)2,541,0092,541,0090$6.76M$4.47M1.55%-$2.29M
COMPASS Pathways plcADS(CMPS)964,5001,198,418+233,918$3.65M$3.43M1.19%-$218.3K
Biomea Fusion, Inc.(BMEA)798,757798,7570$3.10M$1.70M0.59%-$1.40M
CalciMedica, Inc.(CALC)521,114521,1140$1.84M$995.3K0.35%-$849.4K
Elevation Oncology Inc (ELEV)2,834,9102,834,9100$1.59M$734.5K0.25%-$853.0K
Aclaris Therapeutics, Inc.(ACRS)434,455434,4550$1.08M$664.7K0.23%-$412.7K
Marker Therapeutics, Inc.(MRKR)325,370325,3700$1.01M$400.2K0.14%-$611.7K
OnKure Therapeutics, Inc.CL A(OKUR)88,60788,6070$762.0K$381.0K0.13%-$381.0K
Poseida Therapeutics Inc. (PSTX)1,043,2670-1,043,267$10.02M$0—-$10.02M
Viracta Therapeutics Inc (VIRX)288,5710-288,571$46.2K$0—-$46.2K
Page 1 of 1
Aisling Capital Management LP — 13F Holdings — Q1 2025 | TickerTrail